overview of the cll13 trial: replacing chemotherapy with venetoclax-containing regimens
Published 8 years ago • 524 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:39
overview of the cllr3 trial of obinutuzumab
-
1:31
frontline treatment for cll: the changing paradigm
-
4:03
a review of current and future directions of clinical trials for cll
-
1:54
covid-19 in the gaia/cll13 trial
-
0:41
recent advances in understanding and managing ctcl
-
1:00
the future of cll treatment: chemotherapy and targeted inhibitors
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
4:51
current treatment options for cll
-
3:48
ctcl overview (chapter 1)
-
3:40
the role of dll3-directed agents in treating sclc
-
27:49
what's new with cll treatments w/top expert | dr. william wierda, md anderson | the patient story
-
2:04
murano trial: revolutionizing the standard of care for relapsed cll patients
-
1:28
the future of cll treatment
-
2:44
the structure and function of bcrs in the biology of cll
-
17:52
diagnosis and initial treatment of cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:44
upcoming cll trials on treatment options
-
3:29
how the management of cll is evolving
-
2:51
the optimum approach to frontline treatment of cll in 2021
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
1:43
some insights into bruin cll-322: a trial in progress